about
Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007Transmissibility and geographic spread of the 1889 influenza pandemicIschemic colitisA comparative analysis of Chikungunya and Zika transmissionDoes the effectiveness of control measures depend on the influenza pandemic profile?A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009.Mortality burden of the 1918-1919 influenza pandemic in EuropeEarly estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases.Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009-2010.Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries.Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review.Open data in public health surveillance systems: a case study using the French Sentinelles network.Phototherapeutic keratectomy for BIGH3-linked corneal dystrophy recurring after penetrating keratoplasty.Detailed contact data and the dissemination of Staphylococcus aureus in hospitals.A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data.ISHAPE: new rapid and accurate software for haplotyping.Risk assessment of transmission of sporadic Creutzfeldt-Jakob disease in endodontic practice in absence of adequate prion inactivationAntibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.Modelling the effects of population structure on childhood disease: the case of varicella.Risk factors of influenza transmission in householdsImproving disease incidence estimates in primary care surveillance systems.Clinical outcome of eight BIGH3-linked corneal dystrophies.Determination of French influenza outbreaks periods between 1985 and 2011 through a web-based Delphi methodPulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis.Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.Accuracy of ICD-10 codes for surveillance of Clostridium difficile infections, FranceImpaired cortical processing of inspiratory loads in children with chronic respiratory defects.Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus ErythematosusImproving incidence estimation in practice-based sentinel surveillance networks using spatial variation in general practitioner densityThe perpetuation and epidemic recurrence of communicable diseases in human populations.Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional studySevere Extra-Cerebral Anticoagulant-Related Bleeding in Intensive Care Unit: A Retrospective Study From 2000 to 2013.Peripatetic health-care workers as potential superspreaders.Commuter mobility and the spread of infectious diseases: application to influenza in France.Contribution of mathematical modeling to the fight against bacterial antibiotic resistance.Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.Epidemiology and treatment of painful procedures in neonates in intensive care units.Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge.
P50
Q21144638-907F033A-EC72-4B9E-937F-6180F27B6E28Q24631312-5BFAAFD5-74A4-4FC0-842F-29DBA609D7FEQ28270849-D2C48B5F-1746-48BB-AEE4-423ABC1C4A5CQ28595137-123A4C89-B813-49C0-AF1F-9D9F7E29DF71Q30367271-97ED3DB0-49A1-4549-86F9-8C9EAC9E0DE5Q30377089-9433AF47-DD6E-430D-93D1-A3F9B1E72600Q30377243-764CCC30-AA54-46CD-96B1-067031D11D6DQ30381485-607D5A86-0859-429A-9C26-DB5C5709D781Q30386660-5F90FCC9-7682-4A18-A63E-BFB67FC79943Q30403272-5B40F5D2-8233-4FC8-8E88-7805C12BC5CAQ30403791-209CC8FD-1AEC-461F-B93E-7B0BD14C8E80Q30486242-868EDFE9-CBC6-46E7-AE5F-4EA70D95720FQ30727586-A828B6A3-4FFC-4AA3-8C21-FE28FC9A06FBQ30912406-40F216CB-F230-4387-BDE6-65BF8463A5F9Q30972878-8FDB94D0-5BD6-4E67-A100-DE9030D22FCEQ33287969-E8D67102-C3BA-49CE-AEBB-F946233D1927Q33312361-E59B7251-6881-40B0-82F3-4A0420ECA809Q33332126-1E1C71FA-0497-4375-9282-4083E00E6C0AQ33370549-5471F14D-A36A-40BD-834A-D8326D38F72FQ33981247-BAE8811B-824A-4CC2-97C8-B499EE4A6220Q34249434-42DF8DA0-DE45-4BB2-B4D0-009FBA5B1D91Q34571884-1047524D-8BA9-4C4C-A5A0-8F355B911BF1Q34584010-F29150B9-3856-4A54-9FFA-F02C97B94B2BQ35074578-E3077705-89DA-4C11-9CEC-B90CE631D2BCQ35929774-19EF8EC4-31A7-4B54-B211-70D8DDC693BCQ35934114-5390D315-E583-4520-864C-D1739C6FDEF6Q35979913-E3CBE27D-1446-4F1B-BF9E-CAB52F2CE32CQ36062976-5847509F-92C7-4F70-824D-F475074927A9Q36134326-87C06CD8-257E-48FA-8980-C0CF7524AD5DQ36193216-EE045BD6-658A-42C9-B415-B494272C6546Q36821727-2642CEBD-00E5-4FB7-9B8F-92F5A2C98A99Q37156281-C2E0152B-6C65-45BC-A1CB-FB76DC0C4283Q37328730-6D5942BE-2818-4F11-9C5D-16BF4AECE1BCQ37416589-E37689A3-0107-48BD-B0E1-09BB93143BB0Q37458517-1F8FB86E-038E-4A3B-B822-21FBA88A4E0BQ37862035-4491132F-491F-4855-A53C-685689640484Q38177767-E66826AA-8E09-4C88-8223-919BA24D93DEQ38415533-44164165-45DC-4705-BEB1-CC6420773ADDQ38455469-21292C79-A6A9-40FB-A983-32DD23CE4251Q38529613-99D033B0-480E-4C80-B3BA-DD10C2C0E5AB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pierre-Yves Boëlle
@ast
Pierre-Yves Boëlle
@en
Pierre-Yves Boëlle
@es
Pierre-Yves Boëlle
@nl
Pierre-Yves Boëlle
@sl
type
label
Pierre-Yves Boëlle
@ast
Pierre-Yves Boëlle
@en
Pierre-Yves Boëlle
@es
Pierre-Yves Boëlle
@nl
Pierre-Yves Boëlle
@sl
prefLabel
Pierre-Yves Boëlle
@ast
Pierre-Yves Boëlle
@en
Pierre-Yves Boëlle
@es
Pierre-Yves Boëlle
@nl
Pierre-Yves Boëlle
@sl
P106
P21
P2456
P31
P496
0000-0002-5367-8232